Zota Health Care Limited

NSE ZOTA.NS

Zota Health Care Limited Current Liabilities for the year ending March 31, 2024: USD 8.83 M

Zota Health Care Limited Current Liabilities is USD 8.83 M for the year ending March 31, 2024, a 79.21% change year over year. Current liabilities are obligations that are expected to be settled within one year, including accounts payable, short-term debt, and other current liabilities.
  • Zota Health Care Limited Current Liabilities for the year ending March 31, 2023 was USD 4.93 M, a 4.09% change year over year.
  • Zota Health Care Limited Current Liabilities for the year ending March 31, 2022 was USD 4.74 M, a 90.25% change year over year.
  • Zota Health Care Limited Current Liabilities for the year ending March 31, 2021 was USD 2.49 M, a 0.88% change year over year.
  • Zota Health Care Limited Current Liabilities for the year ending March 31, 2020 was USD 2.47 M, a -13.43% change year over year.
Key data
Date Current Liabilities Total Non-Current Liabilities Shareholders' Equity Long-Term Debt
Market news
Loading...
SV Wall Street
NSE: ZOTA.NS

Zota Health Care Limited

CEO Dr. Sujit Paul
IPO Date May 10, 2017
Location India
Headquarters Zota House
Employees 445
Sector Healthcare
Industries
Description

Zota Health Care Limited develops, manufactures, and markets pharmaceutical products in India. It offers generic drugs, over-the-counter products, ayurvedic products, and nutraceutical products. The company provides various medicines for chronic illnesses, including heart disease, diabetes, thyroid, and others. As of March 31, 2021, it operated 591 retail stores under the DAVAINDIA name in 24 states of India. The company was founded in 1995 and is headquartered in Surat, India.

Similar companies

THEMISMED.NS

Themis Medicare Limited

USD 2.62

1.36%

SMSPHARMA.NS

SMS Pharmaceuticals Limited

USD 2.33

0.83%

SMSLIFE.NS

SMS Lifesciences India Limited

USD 14.45

-2.07%

VIDHIING.NS

Vidhi Specialty Food Ingredients Limited

USD 5.70

-1.96%

LINCOLN.NS

Lincoln Pharmaceuticals Limited

USD 8.26

2.40%

StockViz Staff

February 2, 2025

Any question? Send us an email